Trial intelligence / Profile preview

Therapeutic efficacy testing of artemether + lumefantrine versus artesunate + amodiaquine in children with uncomplicated falciparum malaria

PACTR201510001189370Completed

Sponsor
National Malarial and Vector Control Division
Start
May 2009
Modality
Small Molecules
Countries
1
01

Overview

Trial of artemether, lumefantrine, artesunate and amodiaquine in malaria and Falciparum malaria (PF), sponsored by National Malarial and Vector Control Division. Started May 2009; status: completed.

02

Drugs

artemetherlumefantrineartesunateamodiaquine
03

Conditions

malariaFalciparum malaria (PF)

Beyond the preview

Go deeper on PACTR201510001189370.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201510001189370.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call